Show simple item record

dc.contributor.authorHelal, Ayman
dc.contributor.authorAhmad, Nasir
dc.contributor.authorBajmmal, Omar
dc.contributor.authorEhtisham, Javed
dc.contributor.authorHogrefe, Kai
dc.contributor.authorRaju, Prashanth
dc.contributor.authorSharman, David
dc.contributor.authorShaukat, Naeem
dc.contributor.authorFarooq, Mohsin
dc.date.accessioned2025-10-07T15:47:01Z
dc.date.available2025-10-07T15:47:01Z
dc.date.issued2025-06-01
dc.identifier.citationHelal A, Ahmad N, Bajmmal O, Ehtisham J, Hogrefe K, Raju P, Sharman D, Shaukat N, Farooq M. Orbital Atherectomy in Calcified Coronary Lesions: A 1-Year Retrospective Observational Outcome Study. Catheter Cardiovasc Interv. 2025 Jun;105(7):1572-1577. doi: 10.1002/ccd.31502en_US
dc.identifier.other10.1002/ccd.31502
dc.identifier.urihttp://hdl.handle.net/20.500.12904/19817
dc.description.abstractBackground Percutaneous coronary intervention (PCI) has advanced rapidly since its inception. Not only in stent technology, but there have been advancements in adjunctive tools including intra-coronary imaging, stent delivery tools and calcium modification techniques. The interventional community is well aware of the difficulties posed by calcified coronary lesions and their impact on outcomes. More recently, orbital atherectomy (OA) has seen itself on the fore front of managing such complex and challenging situations. Aims This retrospective study analyses a 1-year experience of using OA in a high-volume primary PCI center in a UK district general hospital. Methods Patient demographics, procedural details, and outcomes, including MACE rates and procedural success, were reviewed in all-comers undergoing OA between January 1 and December 31, 2024. Results A total 53 patients were identified that had undergone OA in a 1-year period. Procedural success was achieved in 98.1% of patients. Thirty-days MACE was 5.7% (three patients). One patient experiencing in-hospital procedural related myocardial infarction and two patients had major bleeding events during the follow up period which is not related to OA. No-flow/slow-flow were observed in seven patients (13.2%), and seven patients (13.2%) experienced coronary dissection that were successfully treated with stent implantation. Conclusion OA is a new but safe and effective tool for calcium modification in an all-comers cohort of patients treated in a high-volume UK district general hospital setting.
dc.description.urihttps://onlinelibrary.wiley.com/doi/10.1002/ccd.31502en_US
dc.language.isoenen_US
dc.subjectAtherectomy, Coronaryen_US
dc.subjectCoronary Artery Diseaseen_US
dc.titleOrbital Atherectomy in Calcified Coronary Lesions: a 1-year retrospective observational outcome studyen_US
dc.typeArticleen_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US
rioxxterms.versionNAen_US
rioxxterms.typeJournal Article/Reviewen_US
refterms.panelUnspecifieden_US
refterms.dateFirstOnline2025-03-17
html.description.abstractBackground Percutaneous coronary intervention (PCI) has advanced rapidly since its inception. Not only in stent technology, but there have been advancements in adjunctive tools including intra-coronary imaging, stent delivery tools and calcium modification techniques. The interventional community is well aware of the difficulties posed by calcified coronary lesions and their impact on outcomes. More recently, orbital atherectomy (OA) has seen itself on the fore front of managing such complex and challenging situations. Aims This retrospective study analyses a 1-year experience of using OA in a high-volume primary PCI center in a UK district general hospital. Methods Patient demographics, procedural details, and outcomes, including MACE rates and procedural success, were reviewed in all-comers undergoing OA between January 1 and December 31, 2024. Results A total 53 patients were identified that had undergone OA in a 1-year period. Procedural success was achieved in 98.1% of patients. Thirty-days MACE was 5.7% (three patients). One patient experiencing in-hospital procedural related myocardial infarction and two patients had major bleeding events during the follow up period which is not related to OA. No-flow/slow-flow were observed in seven patients (13.2%), and seven patients (13.2%) experienced coronary dissection that were successfully treated with stent implantation. Conclusion OA is a new but safe and effective tool for calcium modification in an all-comers cohort of patients treated in a high-volume UK district general hospital setting.en_US
rioxxterms.funder.project94a427429a5bcfef7dd04c33360d80cden_US


This item appears in the following Collection(s)

Show simple item record